Pain, immunity, opiate and opioid compounds and health

Medical Science Monitor

Volumn 11, Issue 5, 2005, Pages

  Stefano, George B ^a   Fricchione, Gregory L ^b   Goumon, Yannick ^c   Esch, Tobias ^d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSERM   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

3 opiate receptor; Amygdala; Enkelytin; Methionine enkephalin; Morphine; Nitric oxide; Opioid peptides; Pain

Indexed keywords

ENKELYTIN; METENKEPHALIN; MU 3 OPIATE RECEPTOR; MU OPIATE RECEPTOR; NITRIC OXIDE; OPIATE; OPIATE DERIVATIVE; PROENKEPHALIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DOWN REGULATION; EVOLUTION; EXCITATION; HEALTH; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; MORPHINE ADDICTION; PAIN;

AMINO ACID SEQUENCE; ANIMALS; DRUG TOLERANCE; ENKEPHALINS; EVOLUTION, MOLECULAR; HUMANS; MOLECULAR SEQUENCE DATA; MORPHINE; NARCOTICS; OPIOID PEPTIDES; PAIN; PROTEIN PRECURSORS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTANCE-RELATED DISORDERS;

EID: 20344389037     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Stefano GB, Gadet P, Zhu W et al: The blueprint for stress can be found in invertebrates. Neuroendocrinology Letters, 2002; 23: 85-93
2. Esch T, Stefano GB, Fricchione GL, Benson H: The role of stress in neurodegenerative diseases and mental disorder's. Neuroendocrinology Letters, 2002; 23: 199-208
3. Stefano GB, Fricchione GL: The biology of deception: The evolution of cognitive coping as a denial-like process. Med Hypotheses, 1995; 44: 311-14
4. Esch T, Stefano GB, Fricchione GL, Benson H: Stress-related diseases: A potential role for nitric oxide. Medical Science Monitor, 2002; 8(6): RA103-RA118
5. Stefano GB, Fricchione GL: The biology of deception: Emotion and morphine. Med Hypotheses. 1995; 49: 51-54
6. Stefano GB, Scharrer B, Smith EM et al: Opioid and opiate immunoregulatory processes. Crit Rev in Immunol, 1996; 16: 109-44
7. Stefano GB, Salzet M: Invertebrate opioid precursors: evolutionry conservation and the significance of enzymatic processing. Int Rev Cytol. 1999; 187: 261-86
8. Stefano GB, Salzet B, Fricchione GL: Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today, 1998; 19: 265-68
9. Tasiemski A, Salzet M, Benson H et al: The presence of opioid and antibacterial peptides in human plasma during coronary artery bypass surgery. J Neuroimmunol, 2000; 109: 228-35
10. Chapman CR: Pain: The perception of noxious events. In: Sternbach RA. editor. The psychology of pain. New York: Raven Press, 1978; 169-202
11. Esch T, Guarna M, Bianchi E et al: Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit. 2004; 10(6): MS6-MS17
12. Esch T, Stefano GB: The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinology Letters, 2004; 25: 235-51
13. Slingsby BT, Stefano GB: Placebo: Harnessing the power within. Modern Aspects of Immunobiology, 2000; 1: 144-46
14. Slingsby BT, Stefano GB: The active ingredients in the sugar pill: Trust and belief. Placebo, 2001; 2: 33-38
15. Stefano GB, Fricchione GL, Slingsby BT, Benson H: The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Research: Brain Research Review's. 2001; 35: 1-19
16. Stefano GB, Gotimon Y, Casares F et al: Endogenous morphine. Trends in Neurosciences, 2000; 9: 436-42
17. Stefano GB, Cadet P, Rialas CM et al: Invertebrate Opiate Immune and Neural Signaling. In: Machelska H, Stein C, editors. Immune Mechanisms of Pain and Analgesia. New York. NY: Plenum Publ., 2003: 126-47
18. Zhu W, Ma Y, Cadet P et al: Presence of reticuline in rat brain: A pathway for morphine biosynthesis. Mol Brain Res, 2003; 117: 83-90
19. Zhu W, Ma Y, Bell A et al: Presence of morphine in rat amygdala: Evidence for the 3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit, 2004; 10(12): BR433-BR439
20. Zhu W, Stefano GB: Reticuline exposure to invertebrate Ganglia increases endogenous morphine levels. Neuro Endocrinol Lett, 2004; 25: 323-30
21. Poeaknapo C, Schmidt J, Brandsch M et al: Endogenous formation of morphine in human cells. Proceedings of the National Academy of Sciences of the USA, 2004; 101: 14091-96
22. Cadet P, Mantione KJ, Stefano GB: Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. Journal of Immunology, 2003; 170: 5118-23
23. Stefano GB, Leung MK, Bilfinger TV, Scharrer B: Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunecytes to stimulatory molecules. J Neuroimmunol, 1995; 63: 175-81
24. Stefano GB: Autoimmunovascular regulation: morphine and anandamide stimulated nitric oxide release. Journal of Neuroimmunology, 1998; 83: 70-76
25. Stefano GB, Salzet M, Bilfinger TV: Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of Nitric Oxide. J Cardiovasc Pharmacol, 1998; 31: 862-68
26. Stefano GB, Salzet M, Rialas C et al: Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int J Cardiol, 1998; 64: S3-S13
27. Magazine HI, Chang J, Goumon Y, Stefano GB: Rebound front nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J Immunol, 2000; 165: 102-7
28. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A: Endogenous codeine and morphine are stored in specific brain neurons. Brain Res, 1993; 627: 210-15
29. Bianchi E, Guarna M, Tagliamonte A: Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol, 1994; 4: 83-92
30. Prevot V, Rialas C, Groix D et al: Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res, 1998; 790: 236-44
31. Howard M, O'Garra A, Ishida H et al: Biological properties of interleukin 10. J Clin Immunol. 1992; 12: 239-48
32. Moore KW, O'Garra A, de Waal Malefy TR et al: Interleukin-10. Ann Rev Immunol, 1993; 11: 165-90
33. Smith EM, Hughes TK, Hashemi F, Stefano CB: Immunosuppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA, 1992; 89: 782-86
34. Stefano GB, Schauer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol, 1994; 4: 57-68
35. Bilfinger TV, Stefano GB: Evidence of immunocyte stimulatory molecules(s) in plasma of patients undergoing cardiopulmonary bypass. J Cardiovasc Surg. 1993; 34: 129-33
36. Brix-Christensen V, Tonnesen E, Sanchez RG et al: Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response? Int J Cardiol, 1997; 62: 191-97
37. Stefano GB, Cadet P, Dokun A, Scharrer B: A neuroimmunoregulatory-like mechanism responding to electrical shock in the marine bivalve Mytilus edulis. Brain Behav Immun, 1990; 4: 323-29
38. Bilfinger TV, Fricchione GL, Stefano GB: Nenroimniune implications of cardiopulmonary bypass. Adv Neuroimmunol. 1993; 3: 277-88
39. Stefano GB, Digenis A, Spector S et al: Opiatelike substances in an invertebrate, a novel opiate receptor on inveitebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA, 1993; 90: 11099-103
40. Mantione K, Zhu W, Rialas C et al: Morphine-6-glucuronide stimulates nitric oxide release in mussel neui'al tissues: Evidence for a morphine-6-glucuronide opiate receptor subtype. Cellular A: Molecular Life Sciences, 2002; 59: 570-74
41. Zhu W, Baggerman G, Goumon Y et al: Presence of morphine and morphine-6-glucoronide in the marine mollusk Mytilus edulis ganglia determined by GC/MS and Q-TOF-MS. Starvation increases opiate alkaloid levels. Brain Res Mol Brain Res, 2001; 88: 155-60
42. Zhu W, Baggerman G, Goumon Y et al: Identification of morphine and morphine-6-glucnrotiide in the adrenal medullary chromaffin PC-12 cell line by nano electrospray ionization double quadrupole orthogonal acceleration time of flight mass spectrometix Eur J of Mass Spect, 2001; 7: 25-28
43. Zhu W, Bilfinger TV, Baggerman G et al. Presence of endogenous morphine and morphine 6 glucuronide in human heart tissue. International Journal of Molecular Medicine, 2001; 7: 419-22
44. Stefano GB, Scharret B, Bilfinger TV et al: A novel view of opiate tolerance. Adv Neuroimmunol, 1996; 6: 265-77
45. Bilfinger TV, Fimiani C, Stefano GB: Morphine's immunoregulatory actions are not shared by fentanyl. Int J Cardiol, 1998; 64: 61-66
46. Dole VP, Nyswander ME: Heroine addiction - a metabolic disease. Arch Intern Med, 1967; 120: 19-24
47. Goklstein A: Heraine addiction: Neurobiology, pharmacology, and policy. J Psychoactive Drugs, 1991; 23: 123-33
48. Stefano GB, Goumon Y, Bilfinger TV et al: Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress in Neurobiology, 2000; 60: 531-44
49. Stefano GB, Zhu W, Cadet P, Mantione K: Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the m3 opiate receptor subtype: A hormonal role for endogenous morphine. Journal of Physiology and Pharmacology, 2004; 55: 279-88
50. Fricchione GL, Cytryn L, Bilfinger TV, Stefano GB: Cell behavior and signal molecule involvement in a case study of malignant histiocytosis: a negative model of morphine as an immunoregulator. Am J Hematol, 1997; 56: 197-205.
51. Cadet P, Zhu W, Mantione K et al: Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int J Mol Med, 2003; 12: 485-92